LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 1596 | 10512 | 0.1519 | 0.1578 |
MCF 10A | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1517 | 10512 | 0.1444 | 0.1410 |
MCF 10A | Neratinib | 10 | uM | LJP5 | 72 | hr | 962 | 1606 | 10512 | 0.1528 | 0.1592 |
MCF 10A | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10930 | 10692 | 1.0224 | 1.0127 |
MCF 10A | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 962 | 10510 | 10692 | 0.9830 | 0.9902 |
MCF 10A | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 962 | 9787 | 10692 | 0.9155 | 0.9497 |
MCF 10A | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 962 | 8711 | 10692 | 0.8149 | 0.8853 |
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 962 | 6900 | 10692 | 0.6454 | 0.7630 |
MCF 10A | JW-7-24-1 | 10 | uM | LJP6 | 72 | hr | 962 | 1460 | 10692 | 0.1366 | 0.1269 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 8953 | 10512 | 0.8512 | 0.9084 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 2885 | 10692 | 0.2698 | 0.3713 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 6164 | 10512 | 0.5864 | 0.7129 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 2316 | 10692 | 0.2167 | 0.2878 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 3086 | 10512 | 0.2937 | 0.4020 |
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 2012 | 10692 | 0.1882 | 0.2366 |
MCF 10A | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 1923 | 10512 | 0.1831 | 0.2223 |
MCF 10A | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 962 | 1272 | 10692 | 0.1190 | 0.0829 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1276 | 10512 | 0.1216 | 0.0835 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 970 | 10692 | 0.0908 | 0.0014 |
MCF 10A | Dasatinib | 10 | uM | LJP5 | 72 | hr | 962 | 782 | 10512 | 0.0744 | -0.0587 |
MCF 10A | Dasatinib | 10 | uM | LJP6 | 72 | hr | 962 | 514 | 10692 | 0.0481 | -0.1662 |
MCF 10A | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 962 | 2070 | 10512 | 0.1971 | 0.2487 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 962 | 1486 | 10512 | 0.1414 | 0.1344 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 962 | 1384 | 10512 | 0.1316 | 0.1108 |
MCF 10A | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 962 | 1389 | 10512 | 0.1322 | 0.1117 |